Objectifying Subjective Cognitive Decline: The Prognostic Role of Alzheimer Biomarkers

Henrik Zetterberg¹, Jonathan M Schott²

• ¹From the Department of Psychiatry and Neurochemistry (H.Z.), Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease (H.Z., J.M.S.), UCL Institute of Neurology, Queen Square; UK Dementia Research Institute at UCL (H.Z., J.M.S.), London; Hong Kong Center for Neurodegenerative Diseases (H.Z.), Clear Water Bay, China; and Dementia Research Centre (J.M.S.), Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, United Kingdom. henrik.zetterberg@clinchem.gu.se.+1